RxDoctor Payments Data

Susana Leal Khouri, MD

Dermatopathology · Key Biscayne, FLNPI 1871589168

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.7% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Merz North America, Inc. at 31.9% of the total. Reporting peaked in 2019 at $605 and has fallen 90.0% since, to $61 in 2025.

$1,072in general payments, 2019–2025

Across 32 payments — averaging $33.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz North America, Inc.$342
  • Pfizer$238
  • Galderma Laboratories, L.p.$107
  • Musculoskeletal Transplant Foundation Inc.$101
  • Sun Pharmaceutical Industries Inc.$100
  • LEO Pharma Inc.$35
  • plus $148 from 7 others

What the payments were for

  • Food & beverage$97291%
  • Education$1009%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,072 in reported general payments places this provider in the 80th percentile of 62 dermatopathology providers in Florida.

See all dermatopathology providers in Florida

Medicare billing

Part B allowed, 2024
$425,058
Medicare patients
778
Services billed
4,675

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab13$87,538
Cosentyx Sensoready (2 Pens)Secukinumab12$87,129
Clobetasol Propionate196$7,295
Fluorouracil44$4,321
Imiquimod140$3,447
Metronidazole42$2,182
Ciclopirox52$1,924
Triamcinolone Acetonide164$1,731
Mupirocin226$1,630
Fluocinolone AcetonideFluocinolone/Shower Cap25$1,247
Ketoconazole79$1,134
Fluocinolone Acetonide16$1,032
ValacyclovirValacyclovir Hcl11$669
Econazole Nitrate24$632
Ciprofloxacin Hcl38$484

Paid to pharmacies, not to this prescriber.

Other dermatopathology in Key Biscayne

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →